...
search icon

Price related data not available

Quince Therapeutics, Inc. Analyst Forecast

Price related data not available

Quince Therapeutics, Inc. Stock Returns

Time FrameQNCXSectorS&P500
1-Week Return3.03%-1.66%-0.96%
1-Month Return-47.3%-4.76%-2.3%
3-Month Return-97.2%-3.81%-2.15%
6-Month Return-93.41%9.66%0.81%
1-Year Return-92.52%4.4%20.8%
3-Year Return-88.42%19.83%72.98%
5-Year Return-99.73%30.13%68.06%
10-Year Return-99.68%119.85%229.83%

Quince Therapeutics, Inc. Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue332.00K344.00K175.00K322.00K186.00K[{"date":"2020-12-31","value":96.51,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":50.87,"profit":true},{"date":"2023-12-31","value":93.6,"profit":true},{"date":"2024-12-31","value":54.07,"profit":true}]
Gross Profit(332.00K)(344.00K)(175.00K)(322.00K)(186.00K)[{"date":"2020-12-31","value":-33200000,"profit":false},{"date":"2021-12-31","value":-34400000,"profit":false},{"date":"2022-12-31","value":-17500000,"profit":false},{"date":"2023-12-31","value":-32200000,"profit":false},{"date":"2024-12-31","value":-18600000,"profit":false}]
Gross Margin-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses78.89M90.32M52.02M34.62M57.28M[{"date":"2020-12-31","value":87.35,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":57.59,"profit":true},{"date":"2023-12-31","value":38.33,"profit":true},{"date":"2024-12-31","value":63.43,"profit":true}]
Operating Income(78.89M)(90.32M)(52.02M)(34.62M)(57.28M)[{"date":"2020-12-31","value":-7889300000,"profit":false},{"date":"2021-12-31","value":-9031800000,"profit":false},{"date":"2022-12-31","value":-5201500000,"profit":false},{"date":"2023-12-31","value":-3462000000,"profit":false},{"date":"2024-12-31","value":-5728500000,"profit":false}]
Total Non-Operating Income/Expense4.09M993.00K1.14M6.04M3.47M[{"date":"2020-12-31","value":67.7,"profit":true},{"date":"2021-12-31","value":16.45,"profit":true},{"date":"2022-12-31","value":18.86,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":57.52,"profit":true}]
Pre-Tax Income(76.85M)(89.94M)(51.94M)(31.58M)(56.74M)[{"date":"2020-12-31","value":-7684900000,"profit":false},{"date":"2021-12-31","value":-8994500000,"profit":false},{"date":"2022-12-31","value":-5194400000,"profit":false},{"date":"2023-12-31","value":-3158200000,"profit":false},{"date":"2024-12-31","value":-5674100000,"profit":false}]
Income Taxes2.17M(620.00K)(284.00K)(197.00K)87.00K[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-28.58,"profit":false},{"date":"2022-12-31","value":-13.09,"profit":false},{"date":"2023-12-31","value":-9.08,"profit":false},{"date":"2024-12-31","value":4.01,"profit":true}]
Income After Taxes(79.02M)(89.33M)(51.66M)(31.39M)(56.83M)[{"date":"2020-12-31","value":-7901870300,"profit":false},{"date":"2021-12-31","value":-8932500000,"profit":false},{"date":"2022-12-31","value":-5166000000,"profit":false},{"date":"2023-12-31","value":-3138500000,"profit":false},{"date":"2024-12-31","value":-5682800000,"profit":false}]
Income From Continuous Operations(76.85M)(89.94M)(51.66M)(28.02M)(56.83M)[{"date":"2020-12-31","value":-7684900000,"profit":false},{"date":"2021-12-31","value":-8994500000,"profit":false},{"date":"2022-12-31","value":-5166000000,"profit":false},{"date":"2023-12-31","value":-2802500000,"profit":false},{"date":"2024-12-31","value":-5682800000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(76.85M)(89.94M)(51.66M)(31.39M)(56.83M)[{"date":"2020-12-31","value":-7684900000,"profit":false},{"date":"2021-12-31","value":-8994500000,"profit":false},{"date":"2022-12-31","value":-5166000000,"profit":false},{"date":"2023-12-31","value":-3138500000,"profit":false},{"date":"2024-12-31","value":-5682800000,"profit":false}]
EPS (Diluted)(2.63)(3.03)(1.60)(0.85)(1.27)[{"date":"2020-12-31","value":-263,"profit":false},{"date":"2021-12-31","value":-303,"profit":false},{"date":"2022-12-31","value":-160,"profit":false},{"date":"2023-12-31","value":-84.61,"profit":false},{"date":"2024-12-31","value":-127.16,"profit":false}]

Quince Therapeutics, Inc. Ratios

Quince Therapeutics, Inc. Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

QNCX
Cash Ratio 1.01
Current Ratio 1.12

Quince Therapeutics, Inc. Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

QNCX
ROA (LTM) -22.10%
ROE (LTM) -247.78%

Quince Therapeutics, Inc. Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

QNCX
Debt Ratio Lower is generally better. Negative is bad. 0.99
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.01

Quince Therapeutics, Inc. Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

QNCX
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 5.71
Price/FCF NM
EV/R 0.00
EV/Ebitda 1.44

FAQs

What is Quince Therapeutics, Inc. share price today?

Quince Therapeutics, Inc. (QNCX) share price today is $0.1065

Can Indians buy Quince Therapeutics, Inc. shares?

Yes, Indians can buy shares of Quince Therapeutics, Inc. (QNCX) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in QNCX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Quince Therapeutics, Inc. be purchased?

Yes, you can purchase fractional shares of Quince Therapeutics, Inc. (QNCX) via the Vested app. You can start investing in Quince Therapeutics, Inc. (QNCX) with a minimum investment of $1.

How to invest in Quince Therapeutics, Inc. shares from India?

You can invest in shares of Quince Therapeutics, Inc. (QNCX) via Vested in three simple steps:

  • Click on Sign Up or Invest in QNCX stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Quince Therapeutics, Inc. shares
What is Quince Therapeutics, Inc. 52-week high and low stock price?

The 52-week high price of Quince Therapeutics, Inc. (QNCX) is $4.55. The 52-week low price of Quince Therapeutics, Inc. (QNCX) is $0.09.

What is Quince Therapeutics, Inc. price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Quince Therapeutics, Inc. (QNCX) is

What is Quince Therapeutics, Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Quince Therapeutics, Inc. (QNCX) is 5.71

What is Quince Therapeutics, Inc. dividend yield?

The dividend yield of Quince Therapeutics, Inc. (QNCX) is 0.00%

What is the Market Cap of Quince Therapeutics, Inc.?

The market capitalization of Quince Therapeutics, Inc. (QNCX) is $5.93M

What is Quince Therapeutics, Inc.'s stock symbol?

The stock symbol (or ticker) of Quince Therapeutics, Inc. is QNCX

How Can Investors Use Quince Therapeutics, Inc. Share Price Data for Long-Term Investment Decisions?

Consider the share price of Quince Therapeutics, Inc. as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Quince Therapeutics, Inc. has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Quince Therapeutics, Inc. shares for Indian investors?

When investing in Quince Therapeutics, Inc. shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Quince Therapeutics, Inc. stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Quince Therapeutics, Inc. share price with other stocks in the same sector?

Rather than merely checking the share price of Quince Therapeutics, Inc. and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Quince Therapeutics, Inc. stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top